In Gastroenterology Peter Siersema described the currently used treatment modalities for complex esophageal strictures, based on underlying cause and symptom duration, but also focusing on future treatment perspectives.Benign esophageal strictures are frequently seen in clinical practice. Benign esophageal strictures are caused by a variety of esophageal disorders, including radiotherapy-induced and caustic injuries, eosinophilic esophagitis, and strictures after surgical resection for esophageal cancer.
Most endoscopic resection esophageal strictures can be treated by endoscopic dilation, but a minority are found to be refractory or recurring after several dilation sessions. For these complex strictures, additional treatment modalities have become available, including endoscopic incisional therapy and stent placement, which can be selected on the basis of symptom duration and underlying cause.
This article presents a stepwise algorithm for the clinical management of patients with benign esophageal strictures, including a rational use of currently available treatment modalities.
Peter Siersema is member of theme Tumors of the digestive tract.
Related news items
Electronic nose smells precursor of oesophageal cancer5 March 2020
A portable electronic nose can effectively detect precursors of oesophageal cancer, reported by RIHS researchers Yonne Peters and Peter Siersema in the medical science journal GUT. This was demonstrated in an initial study involving more than four hundred patients.read more
Barrett oesophagus6 June 2019
In Nature Reviews Disease Primers Yonne Peters and Ali Al-Kaabi provided a global overview of Barrett oesophagus and outlined key open research questions. This primer covered epidemiology, disease mechanism, diagnose, screening, prevention, management, and quality of life.read more
Low risk of progression in persistent non-dysplastic Barrett’s esophagus19 September 2018
In Clinical Gastroenterology and Hepatology Peter Siersema and Yonne Peters showed that patients with stable persistence of non-dysplastic Barrett’s esophagus have a low risk of malignant progression and may not benefit from routine endoscopic surveillance.read more